Burgess L H, Handa R J
Department of Cell Biology, Neurobiology, and Anatomy, Loyola University, Stritch School of Medicine, Maywood, Illinois 60153.
Endocrinology. 1992 Sep;131(3):1261-9. doi: 10.1210/endo.131.3.1324155.
The effect of estrogen (E) on the hypothalamic-pituitary-adrenal axis was investigated in female Sprague-Dawley rats. Animals were bilaterally ovariectomized (OVX), and a Silastic capsule (0.5 cm) containing 17 beta-estradiol was sc implanted. Control animals received a blank capsule. Animals were killed 21 days later. In E-treated rats, we found significantly higher corticosterone (CORT) peak levels 20 min after a 5-sec footshock (1.0 mamp) or exposure to ether vapors (P less than 0.05) compared to those in OVX controls. In addition, the recovery of the ACTH and CORT responses to footshock stress was significantly prolonged (P less than 0.05) in the presence of E. Furthermore, the ACTH and CORT secretory responses to ether stress could be suppressed by exogenous RU 28362 (a specific glucocorticoid receptor agonist; 40 micrograms/100 g BW for 4 days) in OVX controls (P less than 0.05), but not in E-treated animals. These data suggest that E can impair glucocorticoid receptor-mediated delayed or slow negative feedback. Consequently, we examined the influence of E on mineralocorticoid and glucocorticoid receptor concentrations using in vitro binding assays. E did not alter mineralocorticoid or glucocorticoid receptor concentrations in any of the brain regions examined. The administration of RU 28362 (40 micrograms/100 g BW for 4 days) to OVX control or E-treated rats significantly down-regulated hippocampal glucocorticoid receptor (P less than 0.02) in control rats only. In contrast, aldosterone administration (40 micrograms/100 g BW for 4 days) significantly down-regulated hippocampal glucocorticoid receptor (P less than 0.0008) in both control and E-treated animals. Thus, E treatment results in a loss of the glucocorticoid receptor's ability to autoregulate; this suggests that E may cause a functional impairment of the glucocorticoid receptor even though receptor binding appears normal. These findings suggest that hyperactivation of the hypothalamic-pituitary-adrenal axis after stress in E-treated rats is due in part to impaired glucocorticoid receptor-mediated slow negative feedback.
在雌性斯普拉格-道利大鼠中研究了雌激素(E)对下丘脑-垂体-肾上腺轴的影响。将动物双侧卵巢切除(OVX),并皮下植入含17β-雌二醇的硅橡胶胶囊(0.5厘米)。对照动物植入空白胶囊。21天后处死动物。与OVX对照相比,在接受E治疗的大鼠中,我们发现5秒足部电击(1.0毫安)或暴露于乙醚蒸汽后20分钟时,皮质酮(CORT)峰值水平显著更高(P<0.05)。此外,在有E存在的情况下,促肾上腺皮质激素(ACTH)和CORT对足部电击应激的反应恢复显著延长(P<0.05)。此外,在OVX对照中,外源性RU 28362(一种特异性糖皮质激素受体激动剂;40微克/100克体重,持续4天)可抑制ACTH和CORT对乙醚应激的分泌反应(P<0.05),但在接受E治疗的动物中则不能。这些数据表明E可损害糖皮质激素受体介导的延迟或缓慢负反馈。因此,我们使用体外结合试验研究了E对盐皮质激素和糖皮质激素受体浓度的影响。在所检测的任何脑区中,E均未改变盐皮质激素或糖皮质激素受体浓度。仅在对照大鼠中,给OVX对照或接受E治疗的大鼠注射RU 28362(40微克/100克体重,持续4天)可显著下调海马糖皮质激素受体(P<0.02)。相比之下,给予醛固酮(40微克/100克体重,持续4天)可在对照和接受E治疗的动物中均显著下调海马糖皮质激素受体(P<0.0008)。因此,E治疗导致糖皮质激素受体自身调节能力丧失;这表明E可能导致糖皮质激素受体功能受损,尽管受体结合似乎正常。这些发现表明,接受E治疗的大鼠在应激后下丘脑-垂体-肾上腺轴的过度激活部分归因于糖皮质激素受体介导的缓慢负反馈受损。